Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: A phase I/II study

Journal of Rheumatology

Volumn 23, Issue 5, 1996, Pages 919-924

  Giannini, Edward H ^a,b,f   Lovell, Daniel J ^a,b   Silverman, Earl D ^c   Sundel, Robert P ^d   Tague, B Link ^b   Ruperto, Nicolino ^e  

^a Department of Pediatrics ^*  (United States)

^b Children's Hospital Medical Center   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PAVIA   (Italy)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Clinical trial; IVIG; JRA; Therapy

Indexed keywords

ANTIRHEUMATIC AGENT; DIPHENHYDRAMINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; JUVENILE RHEUMATOID ARTHRITIS; MALE; MULTICENTER STUDY; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TACHYCARDIA; VOMITING;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PILOT PROJECTS; PREDNISONE; TREATMENT OUTCOME;

EID: 0029982473     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Laxer RM, Silverman ED: The pharmacological management of juvenile chronic arthritis. In: Bailliere's Clinical Paediatrics, vol 3. London: Grune & Stratton, 1995:825-73.
2. Newburger JW, Takahashi M, Beiser AS, et al: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
3. Blanchette VS, Luke B, Andrew M, et al: A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-95.
4. NIH Consensus Development Conference. Intravenous immunoglobulin: Prevention and treatment of disease. Consensus Statement. NIH Consens Dev Conf Consens Statement 1990;8:1-23.
5. Collet E, Dalac S, Maerens B, Courtois JM, Izac M, Lambert D: Juvenile dermatomyositis: Treatment with intravenous gammaglobulin. Br J Dermatol 1994;130:231-4.
6. Tumiati B, Casoli P, Veneziani M, Rinaldi G: High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis. Arthritis Rheum 1992;35:1126-33.
7. Dwyer JM: Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107-16.
8. Silverman ED, Laxer RM, Greenwald M, et al: Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1990;33:1015-22.
9. Prieur AM, Adleff A, Debre M, Boulate P, Griscelli C: High dose immunoglobulin therapy in severe juvenile chronic arthritis: Long-term follow-up in 16 patients. Clin Exp Rheumatol 1990;8:603-9.
10. Silverman ED, Cawkwell GD, Lovell DJ, et al: Intravenous immune globulin in the treatment of systemic juvenile rheumatoid arthritis: A randomized placebo-controlled trial. J Rheumatol 1994;21:2353-8.
11. Sansome A, Dubowitz V: Intravenous immunoglobulin in juvenile dermatomyositis - Four year review of nine cases. Arch Dis Child 1995;72:25-8.
12. Groothoff JW, van Leeuwen EF: High dose intravenous gammaglobulin in chronic systemic juvenile arthritis. BMJ 1992;296:1362-3.
13. Uziel Y, Laxer R, Schneider R, Silverman ED: Intravenous immunoglobulin therapy in systemic juvenile rheumatoid arthritis: Follow up study (abstr). Arthritis Rheum 1993;(suppl):S60.
14. Giannini EH, Lovell DJ, Hepburn B: FDA draft guidelines for the clinical evaluation of antiinflammatory and antirheumatic drugs in children. Executive summary. Arthritis Rheum 1995;38:715-8.
15. Giannini EH, Brewer EJ: Standard methodology for segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. II. Analysis and presentation of data. J Rheumatol 1982;9:114-22.
16. Brewer EJ, Giannini EH: Standard methodology for segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. I. Design. J Rheumatol 1982;9:109-13.
17. Howe S, Levinson J, Shear E, et al: Development of a disability measurement tool for juvenile rheumatoid arthritis. The juvenile arthritis functional assessment report for children and their parents. Arthritis Rheum 1991;34:873-80.
18. Anderson JJ, Firschein HE, Meenan RF: Sensitivity of a health status measure to short-term clinical changes in arthritis. Arthritis Rheum 1989;32:844-50.
19. Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977:8.
20. Giannini EH, Brewer EJ, Kuzmina N, et al: Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med 1992;326:1043-9.
21. Food and Drug Administration: IVIG transmission of Hepatitis C. FDA Med Bull 1994;24:3.
22. Goldsmith D, Feldman B, Singh G, Ostrov B, Greenbaum B, Silverman E: Aseptic meningitis following intravenous immune globulin in children (abstr). Arthritis Rheum 1991;(suppl)34:S121.
23. Sekul EA, Culper EJ, Dalakas MC: Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors. Ann Intern Med 1994;121:259-62.